HLA-DRB1 and COVID-19: We postulate that the amino acid residue polymorphism influences the binding affinity of the antigen peptide of the COVID-19 vaccine to the T cell receptor (TCR) via alteration of the electrostatic potential of the fourth pocket (P4) of HLA-DRβ1, thereby impacting the efficiency of the immune response.